Notified bodies receive numerous questions from legal manufacturers during technical assessments. We cannot always answer them for individual legal manufacturers because this would constitute consultation.
How does combining AI with Lean Management significantly improve efficiency in MedTech engineering? AI, much like IDEs or CAD tools before it, is becoming an essential enabler in reducing friction throughout the product development lifecycle—from onboarding and requirements generation to coding and testing—ultimately enhancing both productivity and innovation. By identifying and targeting inefficiencies using Lean principles, MedTech engineering organizations can unlock AI’s full potential to accelerate development and deliver higher-quality healthcare technologies.
Key trends picking up momentum in the field of healthcare. How GenAI is revolutionizing clinical workflows. The rise of ambient technologies in patient care. IoMT devices and SaMD solutions to enable patient care. Interoperability and automation of data. Cybersecurity to ensure the safety of personal data.
In the medical device industry, engineering quality is paramount. This is a high-stakes field, and the FDA has zero tolerance for violations. A robust development process not only enhances quality, compliance and efficiency but also boosts profitability.
MTI Viewpoints are insights shared by industry relative to healthcare and the advancement of medical technology.
The AI Training Dataset Market size is projected CAGR of 27.7% in the coming years. By 2024, the market had reached an approximate value of USD 2.82 billion and is forecasted to reach USD 9.58 billion by 2029, according to a new report by MarketsandMarkets™.
Harnessing the power of big data from medical device software offers real-time monitoring, predictive analytics, and personalized treatment plans, significantly enhancing the doctor to patient relationship as well as patient outcomes.
AI has the ability to revolutionize the medical landscape, but to enable this, Quality Engineering is critically important.
CitiusTech Senior VP and Market Head, Healthcare Providers, John Squeo, shares five game-changing shifts that will redefine the future of US healthcare and unlock a more streamlined, accessible and patient-centric system.
Orthogonal worked with Brian Binkowski, to gain a clearer picture of the state of SaMD approvals in the U.S. Following is what they learned about the rate of FDA approvals and clearances and which companies are having the most success getting their products cleared for the U.S. market.
